Trust Co. of Vermont Boosts Stake in Kenvue Inc. $KVUE

Trust Co. of Vermont lifted its stake in Kenvue Inc. (NYSE:KVUE) by 266.8% in the 2nd quarter, HoldingsChannel reports. The firm owned 1,581 shares of the company’s stock after acquiring an additional 1,150 shares during the period. Trust Co. of Vermont’s holdings in Kenvue were worth $33,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently modified their holdings of KVUE. GAMMA Investing LLC increased its stake in shares of Kenvue by 3,092.9% in the 1st quarter. GAMMA Investing LLC now owns 594,176 shares of the company’s stock worth $14,248,000 after purchasing an additional 575,567 shares in the last quarter. NBC Securities Inc. increased its stake in shares of Kenvue by 89,208.3% in the 1st quarter. NBC Securities Inc. now owns 10,717 shares of the company’s stock worth $256,000 after purchasing an additional 10,705 shares in the last quarter. Merit Financial Group LLC increased its stake in shares of Kenvue by 237.8% in the 1st quarter. Merit Financial Group LLC now owns 37,481 shares of the company’s stock worth $899,000 after purchasing an additional 26,387 shares in the last quarter. RFG Advisory LLC increased its stake in shares of Kenvue by 34.5% in the 1st quarter. RFG Advisory LLC now owns 20,386 shares of the company’s stock worth $489,000 after purchasing an additional 5,233 shares in the last quarter. Finally, Vest Financial LLC increased its stake in shares of Kenvue by 6.8% in the 1st quarter. Vest Financial LLC now owns 2,638,279 shares of the company’s stock worth $63,266,000 after purchasing an additional 167,265 shares in the last quarter. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on KVUE shares. Zacks Research upgraded Kenvue to a “strong sell” rating in a research note on Monday, August 11th. Evercore ISI dropped their target price on shares of Kenvue from $23.00 to $18.00 and set an “in-line” rating for the company in a report on Tuesday, September 23rd. JPMorgan Chase & Co. dropped their target price on shares of Kenvue from $27.00 to $26.00 and set an “overweight” rating for the company in a report on Friday, July 25th. Bank of America dropped their target price on shares of Kenvue from $27.00 to $25.00 and set a “buy” rating for the company in a report on Tuesday, July 15th. Finally, Royal Bank Of Canada dropped their target price on shares of Kenvue from $24.00 to $22.00 and set a “sector perform” rating for the company in a report on Friday, August 8th. One analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $22.46.

Kenvue Stock Up 0.4%

Shares of NYSE:KVUE opened at $15.80 on Friday. The company has a current ratio of 0.98, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 12 month low of $15.47 and a 12 month high of $25.17. The company has a 50-day moving average price of $19.71 and a 200 day moving average price of $21.58. The company has a market cap of $30.31 billion, a price-to-earnings ratio of 21.34, a PEG ratio of 2.26 and a beta of 0.72.

Kenvue (NYSE:KVUE) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.29 EPS for the quarter, beating analysts’ consensus estimates of $0.28 by $0.01. The firm had revenue of $3.84 billion during the quarter, compared to the consensus estimate of $3.94 billion. Kenvue had a net margin of 9.37% and a return on equity of 20.06%. The firm’s revenue for the quarter was down 4.0% compared to the same quarter last year. During the same quarter last year, the firm earned $0.32 EPS. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, equities research analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, August 27th. Stockholders of record on Wednesday, August 13th were given a dividend of $0.2075 per share. The ex-dividend date of this dividend was Wednesday, August 13th. This represents a $0.83 annualized dividend and a dividend yield of 5.3%. This is an increase from Kenvue’s previous quarterly dividend of $0.21. Kenvue’s dividend payout ratio is presently 112.16%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.